Matthew R Strickland Selected Research

Matthew R Strickland Research Topics

12	Neoplasms (Cancer) 02/2024 - 08/2012
3	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2023
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2019
2	Adenocarcinoma 02/2024 - 12/2023
2	Carcinogenesis 12/2023 - 01/2019
1	Lymphatic Metastasis 12/2023
1	Carcinoma (Carcinomatosis) 12/2023
1	Anus Neoplasms (Anal Cancer) 11/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Meningeal Carcinomatosis 10/2021
1	Meningioma (Meningiomas) 12/2019
1	Breast Neoplasms (Breast Cancer) 01/2019

3	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2023
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
2	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 11/2023
1	Programmed Cell Death 1 ReceptorIBA 05/2024
1	PlatinumIBA 02/2024
1	pembrolizumabIBA 02/2024
1	InterferonsIBA 02/2024
1	AntibodiesIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	DNA Transposable Elements (Element, IS)IBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	RadiopharmaceuticalsIBA 12/2023
1	Capecitabine (Xeloda)FDA Link 11/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2023
1	adagrasibIBA 01/2022
1	IpilimumabIBA 10/2021
1	NivolumabIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2012
1	Minocycline (Cyclops)FDA LinkGeneric 08/2012

5	Therapeutics 01/2024 - 01/2019
3	Drug Therapy (Chemotherapy) 02/2024 - 01/2024
2	Radiotherapy 02/2024 - 11/2023
2	Chemoradiotherapy 02/2024 - 11/2023
2	Immunotherapy 12/2023 - 11/2023
1	Adjuvant Chemotherapy 01/2024
1	Neoadjuvant Therapy 12/2023
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2023
1	Craniotomy 01/2019